Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Between YHP2508A and YHR2601 in Healthy Subjects
NCT07912827Phase 1Recruiting
- Sponsor
- Yuhan
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2508A (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve and Maximum plasma concentration. Started Oct 2026; status: recruiting.
02
Drugs
YHP2508A
Beyond the preview
Go deeper on NCT07912827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07912827.